Artificial Intelligence

An AI security firm found 38 severe vulnerabilities, some with a 10.0 CVSS score, in a medical records platform, sparking a new era of cyber defense.

FS launches new DCI solutions with zero-touch automation, promising to slash deployment time and costs for data centers swamped by AI traffic.

Now trading as EFOR, the tech giant launches a unified identity to drive growth, but faces questions after a challenging first-quarter financial report.

As ad fraud costs exceed $120B, BrandPilot AI adds a key expert to its advisory board, signaling a renewed assault on invalid traffic and data distortion.

DeepVest launches new AI tools using Nobel Prize-winning theory to offer advisors deeper client insights and hyper-personalized portfolios at scale.

Camber's new service model guarantees 98% EV charger uptime for fleets, automatically waiving fees if performance falls short. Is this the new standard?

A new partnership links Wiz's cloud risk detection directly to C1's identity engine, promising real-time, automated access decisions for the AI era.

A new FDA-Paradigm Health partnership uses AI to review clinical trial data in real time, aiming to cut drug development costs and approval delays.

Copenhagen's Performativ, backed by Deutsche Börse, raises $14M to replace legacy systems with a unified, AI-driven platform for private banks.

Qdrant adds GPU-accelerated indexing, multi-AZ clusters, and audit logs, tackling enterprise needs for AI performance, reliability, and compliance.

As GPS jamming becomes a critical threat, Northrop Grumman's new EGI-M system, powered by Green Hills software, ensures US jets stay on target.

A startup's novel 4D mammography system completes its first human trial, promising to detect cancer's molecular fingerprint and slash false positives.

The firm's unique chip design, integrating lasers on silicon, aims to solve the data bottleneck crippling AI and secures major deep tech investor backing.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

Braze reaffirms its financial outlook while announcing a CFO departure and hiring a new CIO, signaling a dual focus on stability and AI innovation.

Neurogene bets on a direct-to-brain delivery method for its Rett syndrome gene therapy, arguing the established surgical technique offers superior results.

A debt recovery firm won a major award for an AI that trains agents to be more compassionate, improving service and saving $1.5 million annually.

A new wearable using ultrasound resonance could finally solve the accuracy and calibration problems plaguing blood pressure monitors for a billion patients.

Digital asset pioneer CoinShares named Asset Manager of the Year, validating its decade-long strategy of bridging crypto with regulated capital markets.

The advisory firm posted a 29% revenue jump, driven by strong M&A and restructuring, and signaled deep confidence with a massive share repurchase program.